-
-
-
-
-
-
-
-
-
-
公开(公告)号:US12011584B2
公开(公告)日:2024-06-18
申请号:US17324705
申请日:2021-05-19
申请人: Adlore, Inc.
CPC分类号: A61N1/0468 , A61B5/01 , A61B5/0531 , A61B5/14507 , A61B5/14539 , A61F7/007 , A61F7/02 , A61N1/0484 , A61N1/36031 , A61F2007/0043 , A61F2007/0045 , A61F2007/0075 , A61F2007/0078 , A61F2007/0093 , A61F7/032
摘要: Disclosed are methods, devices, and systems for treatment of an abnormal wound healing response. The methods, devices, and systems can be used to treat solid ulcerated tissue, such as diabetic foot ulcers (DFUs), arthritic tissue, muscle soreness, joint pain, varicose veins, obesity, and peripheral artery disease. Additionally, the methods, devices, and systems can promote the healing of xenograft, allograft, autograft, or engineered tissue following reconstruction surgery. The methods, devices, and systems include the ability to determine an optimal set of pulse parameters that are specific to wound healing. In embodiments, the methods, devices, and systems include components for guiding the user on electrode placement based on anatomical or electrical measurements, delivering a custom series of electric pulses, applying heat, and using feedback from physiologic measurements to control the device.
-
-
-
-
-
-
-
-
-